<DOC>
	<DOCNO>NCT01130298</DOCNO>
	<brief_summary>Single-center , single dose , open-label study healthy male female volunteer characterize transfer potential Testosterone Gel 1.62 % formulation .</brief_summary>
	<brief_title>An Open-Label Study Serum Testosterone Levels Non-dosed Females After Secondary Exposure Testosterone Gel 1.62 % Applied Upper Arms Shoulders Use T-shirt Barrier</brief_title>
	<detailed_description>Single-center , single dose , open-label study 12 healthy male 12 healthy female volunteer characterize transfer potential Testosterone Gel 1.62 % formulation .</detailed_description>
	<mesh_term>Testosterone</mesh_term>
	<mesh_term>Testosterone enanthate</mesh_term>
	<mesh_term>Testosterone undecanoate</mesh_term>
	<mesh_term>Testosterone 17 beta-cypionate</mesh_term>
	<mesh_term>Methyltestosterone</mesh_term>
	<criteria>Inclusion Criteria BMI 2035 kg/m^2 inclusive . Exclusion Criteria Males : history , current suspect prostate breast cancer . Females : pregnant lactating .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>June 2011</verification_date>
	<keyword>testosterone , replacement , therapy</keyword>
</DOC>